<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cells isolated directly from primary biopsies of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were found to activate the alternative complement pathway in hypogammaglobulinemic human serum </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast, cells isolated from patients with either <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> did not activate </plain></SENT>
<SENT sid="2" pm="."><plain>No defects in the ability of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> sera to support alternative pathway activation were detected </plain></SENT>
</text></document>